ARADIGM CORP 4
4 · ARADIGM CORP · Filed Sep 8, 2015
Insider Transaction Report
Form 4
ARADIGM CORPARDM
Froehlich Juergen Kurt
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-09-01+8,750→ 8,750 totalExercise: $9.60Exp: 2024-02-13→ Common Stock (8,750 underlying) - Other
Stock Option (Right to Buy)
2015-09-01−37,500→ 0 totalExercise: $9.60Exp: 2024-02-13→ Common Stock (37,500 underlying) - Other
Stock Option (Right to Buy)
2015-09-01−8,750→ 0 totalExercise: $9.60Exp: 2024-02-13→ Common Stock (8,750 underlying) - Award
Stock Option (Right to Buy)
2015-09-01+37,499→ 37,499 totalExercise: $9.60Exp: 2024-02-13→ Common Stock (37,499 underlying)
Footnotes (5)
- [F1]Cancellation of Stock Option granted under the now expired Aradigm Corporation 2005 Equity Incentive Plan.
- [F2]Inapplicable.
- [F3]Granted under Aradigm Corporation 2015 Equity Incentive Plan.
- [F4]One share difference in shares granted versus shares cancelled is due to ISO limits and rounding.
- [F5]Stock option vests 100% upon the satisfaction of certain conditions.